Dose-Response Oxidation of Ingested Phytoglycogen during Exercise in Endurance-Trained Men

BACKGROUND

Phytoglycogen (PHY; PhytoSpherix; Mirexus Biotechnologies), a highly branched polysaccharide extracted from sweet corn, has considerable potential for exercise oxidation due to its low viscosity in water, high water retention, and exceptional stability.

OBJECTIVES

Using gas chromatography-isotope ratio mass spectrometry, we investigated dose-response oxidation of ingested PHY during prolonged, moderate-intensity exercise.

METHODS

Thirteen men (≥1 y endurance-training experience, ≥6 d·wk-1, ∼1-1.5 h·d-1; age, 25.7 ± 5.5 y; mass, 79.3 ± 10.0 kg;  V̇O2max, 59.9 ± 5.5 mL·kg-1·min-1; means ± SDs) cycled for 150 min (50% maximal watt output) while ingesting PHY concentrations of 0.0% (0.0 g·min-1), 3.6% (0.5 g·min-1), 7.2% (1.0 g·min-1), 10.8% (1.5 g·min-1), or 14.4% (2 g·min-1) in water (2100 mL) (n = 7-10/dose). Substrate oxidation was determined using stable-isotope methods and indirect calorimetry.

RESULTS

PHY oxidation plateaued between 60 and 150 min of exercise and increased (P < 0.001) from 0.49 to 0.72 g·min-1 with 0.5- and 1.0-g·min-1 doses without further increases (0.76 and 0.73 g·min-1; P > 0.05) with 1.5 or 2 g·min-1. Peak PHY oxidation (0.84 ± 0.04 g·min-1) occurred in the final 30 min of exercise with 2 g·min-1. Exercise blood glucose was greater (5.1 mmol·L-1) with 1.0-, 1.5-, and 2-g·min-1 doses compared with that of 0.5 (4.7 mmol·L-1) or 0.0 g·min-1 (4.2 mmol·L-1) (P < 0.0001). Gastrointestinal distress was minimal except with 2 g·min-1 (P < 0.001).

CONCLUSIONS

In male endurance athletes, PHY oxidation plateaued at 0.72-0.76 g·min-1 during 150 min of cycling at 50% Wmax (peak oxidation of 0.84 g·min-1 occurred during the final 30 min). This trial was registered at clinicaltrials.gov as NCT02909881.

Gastrointestinal Assessment and Therapeutic Intervention for the Management of Exercise-Associated Gastrointestinal Symptoms: A Case Series Translational and Professional Practice Approach

This translational research case series describes the implementation of a gastrointestinal assessment protocol during exercise (GastroAxEx) to inform individualised therapeutic intervention of endurance athletes affected by exercise-induced gastrointestinal syndrome (EIGS) and associated gastrointestinal symptoms (GIS). A four-phase approach was applied. Phase 1: Clinical assessment and exploring background history of exercise-associated gastrointestinal symptoms. Phase 2: Individual tailored GastroAxEx laboratory simulation designed to mirror exercise stress, highlighted in phase 1, that promotes EIGS and GIS during exercise. Phase 3: Individually programmed therapeutic intervention, based on the outcomes of Phase 2. Phase 4: Monitoring and readjustment of intervention based on outcomes from field testing under training and race conditions. Nine endurance athletes presenting with EIGS, and two control athletes not presenting with EIGS, completed Phase 2. Two athletes experienced significant thermoregulatory strain (peak core temperature attained > 40°C) during the GastroAxEx. Plasma cortisol increased substantially pre- to post-exercise in n = 6/7 (Δ > 500 nmol/L). Plasma I-FABP concentration increased substantially pre- to post-exercise in n = 2/8 (Δ > 1,000 pg/ml). No substantial change was observed in pre- to post-exercise for systemic endotoxin and inflammatory profiles in all athletes. Breath H2 responses showed that orocecal transit time (OCTT) was delayed in n = 5/9 (90-150 min post-exercise) athletes, with the remaining athletes (n = 4/9) showing no H2 turning point by 180 min post-exercise. Severe GIS during exercise was experienced in n = 5/9 athletes, of which n = 2/9 had to dramatically reduce work output or cease exercise. Based on each athlete's identified proposed causal factors of EIGS and GIS during exercise (i.e., n = 9/9 neuroendocrine-gastrointestinal pathway of EIGS), an individualised gastrointestinal therapeutic intervention was programmed and advised, adjusted from a standard EIGS prevention and management template that included established strategies with evidence of attenuating EIGS primary causal pathways, exacerbation factors, and GIS during exercise. All participants reported qualitative data on their progress, which included their previously presenting GIS during exercise, such as nausea and vomiting, either being eliminated or diminished resulting in work output improving (i.e., completing competition and/or not slowing down during training or competition as a result of GIS during exercise). These outcomes suggest GIS during exercise in endurance athletes are predominantly related to gastrointestinal functional and feeding tolerance issues, and not necessarily gastrointestinal integrity and/or systemic issues. GastroAxEx allows for informed identification of potential causal pathway(s) and exacerbation factor(s) of EIGS and GIS during exercise at an individual level, providing a valuable informed individualised therapeutic intervention approach.

Post-Exercise Ingestion of Low or High Molecular Weight Glucose Polymer Solution Does Not Improve Cycle Performance in Female Athletes

ABSTRACT

Mock, MG, Hirsch, KR, Blue, MNM, Trexler, ET, Roelofs, EJ, and Smith-Ryan, AE. Postexercise ingestion of low or high molecular weight glucose polymer solution does not improve cycle performance in female athletes. J Strength Cond Res 35(1): 124-131, 2021-The current study sought to evaluate the effects of postexercise ingestion of a high molecular weight (HMW) glucose polymer solution compared with an isocaloric low molecular weight (LMW) solution or placebo (PLA) on subsequent cycling performance in female athletes. In a randomized, double-blind, placebo-controlled, cross-over design, 10 competitive female cyclists (Mean ± SD; Age = 25.7 ± 5.0 years; V̇o2peak = 49.7 ± 4.3 ml·kg-1·min-1) completed 3 testing sessions separated by 7-10 days. Visits consisted of a ride-to-exhaustion (RTE) at 75% V̇o2peak, followed by immediate consumption of 700 ml containing either: 1.2 g·kg-1 LMW (maltodextrin/dextrose/fructose); 1.2 g·kg-1 HMW (Vitargo); or 0.066 g·kg-1 PLA (noncaloric flavoring). After 2 hours of rest, subjects performed a 15-minute time trial (TT). Respiratory exchange ratio (RER) was assessed via indirect calorimetry during exercise. Total body water (TBW) was measured using bioelectrical impedance to assess fluid balance. When covaried for estrogen, there was no treatment effect on distance (km; p = 0.632) or power output (watts; p = 0.974) during the 15-minute TT. Respiratory exchange ratio was not significantly different during the LMW and HWM TTs (p > 0.999), but both were significantly higher than PLA (p = 0.039, p = 0.001, respectively). Changes in total body water pre-exercise to postexercise were not significantly different between trials (p = 0.777). Despite benefits of HMW on cycling performance previously reported in males, current results demonstrate no ergogenic effect of HMW or LMW in females. Sex differences in substrate utilization may account for the discrepancy, and further research involving performance nutrition for female athletes is merited.

Carbohydrate supplementation: a critical review of recent innovations

PURPOSE

To critically examine the research on novel supplements and strategies designed to enhance carbohydrate delivery and/or availability.

METHODS

Narrative review.

RESULTS

Available data would suggest that there are varying levels of effectiveness based on the supplement/supplementation strategy in question and mechanism of action. Novel carbohydrate supplements including multiple transportable carbohydrate (MTC), modified carbohydrate (MC), and hydrogels (HGEL) have been generally effective at modifying gastric emptying and/or intestinal absorption. Moreover, these effects often correlate with altered fuel utilization patterns and/or glycogen storage. Nevertheless, performance effects differ widely based on supplement and study design. MTC consistently enhances performance, but the magnitude of the effect is yet to be fully elucidated. MC and HGEL seem unlikely to be beneficial when compared to supplementation strategies that align with current sport nutrition recommendations. Combining carbohydrate with other ergogenic substances may, in some cases, result in additive or synergistic effects on metabolism and/or performance; however, data are often lacking and results vary based on the quantity, timing, and inter-individual responses to different treatments. Altering dietary carbohydrate intake likely influences absorption, oxidation, and and/or storage of acutely ingested carbohydrate, but how this affects the ergogenicity of carbohydrate is still mostly unknown.

CONCLUSIONS

In conclusion, novel carbohydrate supplements and strategies alter carbohydrate delivery through various mechanisms. However, more research is needed to determine if/when interventions are ergogenic based on different contexts, populations, and applications.

Carbohydrate dose influences liver and muscle glycogen oxidation and performance during prolonged exercise

This study investigated the effect of carbohydrate (CHO) dose and composition on fuel selection during exercise, specifically exogenous and endogenous (liver and muscle) CHO oxidation. Ten trained males cycled in a double‐blind randomized order on 5 occasions at 77% V˙O2max for 2 h, followed by a 30‐min time‐trial (TT) while ingesting either 60 g·h⁻¹ (LG) or 75 g·h⁻¹¹³C‐glucose (HG), 90 g·h⁻¹ (LGF) or 112.5 g·h⁻¹¹³C‐glucose‐¹³C‐fructose ([2:1] HGF) or placebo. CHO doses met or exceed reported intestinal transporter saturation for glucose and fructose. Indirect calorimetry and stable mass isotope [¹³C] tracer techniques were utilized to determine fuel use. TT performance was 93% “likely/probable” to be improved with LGF compared with the other CHO doses. Exogenous CHO oxidation was higher for LGF and HGF compared with LG and HG (ES > 1.34, P < 0.01), with the relative contribution of LGF (24.5 ± 5.3%) moderately higher than HGF (20.6 ± 6.2%, ES = 0.68). Increasing CHO dose beyond intestinal saturation increased absolute (29.2 ± 28.6 g·h⁻¹, ES = 1.28, P = 0.06) and relative muscle glycogen utilization (9.2 ± 6.9%, ES = 1.68, P = 0.014) for glucose‐fructose ingestion. Absolute muscle glycogen oxidation between LG and HG was not significantly different, but was moderately higher for HG (ES = 0.60). Liver glycogen oxidation was not significantly different between conditions, but absolute and relative contributions were moderately attenuated for LGF (19.3 ± 9.4 g·h⁻¹, 6.8 ± 3.1%) compared with HGF (30.5 ± 17.7 g·h⁻¹, 10.1 ± 4.0%, ES = 0.79 & 0.98). Total fat oxidation was suppressed in HGF compared with all other CHO conditions (ES > 0.90, P = 0.024–0.17). In conclusion, there was no linear dose response for CHO ingestion, with 90 g·h⁻¹ of glucose‐fructose being optimal in terms of TT performance and fuel selection.

O uso do carboidrato antes da atividade física como recurso ergogênico: revisão sistemática

A dieta dos atletas requer aporte energético adequado, sendo a principal fonte energética os carboidratos CHO que são encontrados livremente na corrente sanguínea ou armazenados nos músculos e no fígado. Com base na rotina de treinos e competições, ou mesmo na quantidade exacerbada de energia necessária, é comum a necessidade de suplementação de CHO, seja na forma de bebidas, géis, barras ou balas energéticas, antes, durante ou depois da atividade física. Devido à importância dos CHO foram reunidos estudos que testaram a suplementação com diferentes CHO antes do exercício para aumento da performance. Foram investigados artigos e teses cuja publicação ocorreu a partir de 2006 em bases científicas eletrônicas e banco de teses de faculdades renomadas na área. Os CHO podem ser divididos segundo a quantidade de moléculas que o compõem, as quais também são diferenciadas também por digestão, absorção, viscosidade, dulçor, índice glicêmico IG e oxidação durante a atividade. Comparando-se a taxa de oxidação, foram encontrados melhores resultados quando os CHO ingeridos são de alto teor de IG glicose e sacarose e baixo teor de IG frutose ao se realizar atividade de média a alta intensidade de longa duração. A ingestão de CHO antes do exercício mostrou-se eficiente nos nove estudos analisados, sendo que dois deles apresentaram relevância p < 0,005. Mesmo com a ingestão de CHO com diferentes IG, observou-se melhora, não sendo relatada hipoglicemia de rebote como teorizado na literatura. A suplementação de CHO com a composição e administração apropriadas mostrou-se eficiente para aumento do desempenho físico.

Fructose-maltodextrin ratio governs exogenous and other CHO oxidation and performance

INTRODUCTION

Fructose coingested with glucose in carbohydrate (CHO) drinks increases exogenous-CHO oxidation, gut comfort, and physical performance.

PURPOSE

This study aimed to determine the effect of different fructose-maltodextrin-glucose ratios on CHO oxidation and fluid absorption while controlling for osmolality and caloricity.

METHODS

In a crossover design, 12 male cyclists rode 2 h at 57% peak power then performed 10 sprints while ingesting artificially sweetened water or three equiosmotic 11.25% CHO-salt drinks at 200 mL·15 min, comprising weighed fructose and maltodextrin-glucose in ratios of 0.5:1 (0.5 ratio), 0.8:1 (0.8 ratio), and 1.25:1 (1.25 ratio). Fluid absorption was traced with D2O, whereas C-fructose and C-maltodextrin-glucose permitted fructose and glucose oxidation rate evaluation.

RESULTS

The mean exogenous-fructose and exogenous-glucose oxidation rates were 0.27, 0.39, and 0.46 g·min and 0.65, 0.71, and 0.58 g·min in 0.5, 0.8, and 1.25 ratio drinks, representing mean oxidation efficiencies of 54%, 59%, and 55% and 65%, 85%, and 86% for fructose and glucose, respectively. With the 0.8 ratio drink, total exogenous-CHO oxidation rate was 18% (90% confidence interval, ±5%) and 5.2% (±4.6%) higher relative to 0.5 and 1.25 ratios, respectively, whereas respective differences in total exogenous-CHO oxidation efficiency were 17% (±5%) and 5.3% (±4.8%), associated with 8.6% and 7.8% (±4.2%) higher fructose oxidation efficiency. The effects of CHO ratio on water absorption were inconclusive. Mean sprint power with the 0.8 ratio drink was moderately higher than that with the 0.5 ratio (2.9%; 99% confidence interval, ±2.8%) and 1.25 ratio (3.1%; ±2.7%) drinks, with total- and endogenous-CHO oxidation rate, abdominal cramps, and drink sweetness qualifying as explanatory mechanisms.

CONCLUSIONS

Enhanced high-intensity endurance performance with a 0.8 ratio fructose-maltodextrin-glucose drink is characterized by higher exogenous-CHO oxidation efficiency and reduced endogenous-CHO oxidation. The gut-hepatic or other physiological site responsible requires further research.